Shaw and Partners report, $1.50 target:
http://www.bionomics.com.au/upload/investors/analyst-coverage/35183/Licensing and Trial Results Remain the Key Cataysts Awaited Rather than FY18 Results..pdf
Management Briefing
Shaw and Partners will host a briefing by the directors of BNO in their Adelaide office on
Tuesday 21 August. RSVP to [email protected] for dial in details.